Navigation Links
Clinical Update - Debio 0614 (Istaroxime) in Acute Heart Failure
Date:4/2/2008

LAUSANNE, Switzerland, and POMEZIA, Italy, April 2 /PRNewswire/ --

- Presentation of Phase IIa Efficacy Results

Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist focusing on serious medical conditions, particularly oncology and cardiology, and sigma-tau Industrie Farmaceutiche Riunite SpA (sigma-tau), a leading Italian pharmaceutical group, today presented positive efficacy results of a phase IIa Horizon-HF study with Debio 0614 (formerly PST2744), also known as istaroxime, in development for the treatment of acute heart failure. Data showed that Debio 0614 is able to significantly reduce pulmonary congestion in patients admitted with worsening heart failure and left ventricular dysfunction. These findings were presented at the 57th American College of Cardiology (AAC) Annual Meeting in Chicago, by Mihai Gheorghiade, Professor of Medicine and Surgery at Northwestern University, Chicago and chair of the steering committee of the study.

The results of the study demonstrated that in patients with decompensated heart failure, Debio 0614 improves hemodynamics and diastolic function, without adversely affecting neurohormones or renal function. In this randomized, double-blind, placebo-controlled, multicenter trial, 120 patients were admitted with worsening heart failure, with a left ventricular ejection fraction below 35% and a pulmonary capillary wedge pressure above 20 mmHg. In 30 patients who received three doses of Debio 0614 over six hours, a statistically significant decrease of pulmonary wedge pressure (p<0.03 for all doses) was observed, with a reduction of the left ventricular diastolic volume (p=0.02 for the highest dose) and an increase in cardiac index (p=0.04 for the highest dose), compared to patients treated with placebo.

"Debio 0614 is a novel intravenous agent combining inotropic and lusitropic properties. Its innovative mechanism of action allows for improving systolic and dias
'/>"/>

SOURCE The Debiopharm Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015  Cardica, Inc. (Nasdaq: CRDC ) ... Greg Watson , the company,s vice president of operations, was ... common stock, at a per share exercise price of $0.43, ... option was granted pursuant to Cardica, Inc.,s Inducement Plan, which ... 2015 under Rule 5653(c)(4) of the Nasdaq Global Market for ...
(Date:5/21/2015)... -- Heidrick & Struggles (Nasdaq: HSII ), the premier ... and culture shaping worldwide, strengthens its ... the addition of Tim Dietlin to the ... Dietlin has extensive life sciences and professional services ... and Commercial functions to increase productivity, drive transformational change, ...
(Date:5/21/2015)... Fla. , May 21, 2015 Bankers Healthcare ... is publishing a new blog series from medical writer ... The series will analyze the decision making process, ... and provide insight as to how healthcare practitioners can make ... the series was published May 7, 2015: " Being More ...
Breaking Medicine Technology:Cardica Announces New Employment Inducement Grant 2Heidrick Increases Healthcare and Life Sciences Expertise 2Medical Writer Dr. Pat Bass Publishes A New Series On The Bankers Healthcare Group BHG360 Blog 2Medical Writer Dr. Pat Bass Publishes A New Series On The Bankers Healthcare Group BHG360 Blog 3
... R.I., Nov. 2, 2010 CVS Caremark reiterated the ... (FDA) implement regulations necessary to approve biogeneric drugs under ... of Specialty Pharmacy Operations, Scott Reid, testified before the ... development of an approval pathway for biosimilar and interchangeable ...
... cancer treatments across India will become more widely available ... (NYSE: VAR ) medical linear accelerators by ... groups. Three TrueBeam™ STx systems and a UNIQUE™ accelerator ... Chennai, Mumbai and Hyderabad in 2011. "This ...
Cached Medicine Technology:CVS Caremark Reiterates Support for FDA Implementation of Approval Pathway for Biogeneric Drugs 2Varian Medical Systems to Supply Four Advanced Radiotherapy Treatment Machines to Global Hospitals in India 2Varian Medical Systems to Supply Four Advanced Radiotherapy Treatment Machines to Global Hospitals in India 3
(Date:5/22/2015)... 2015 Coco Libre, the Official Coconut Water ... Record at the 104th running of the race. On Sunday, ... served 315 people in one hour—one person about every 10 ... so true to the heart of the Bay Area, so ... luge to the finish line only made sense,” said Jennifer ...
(Date:5/22/2015)... Building Concepts is experienced with all forms of interior ... include decks, additions, kitchen remodeling, interior renovations, exterior renovations, ... , The redesigned logo is a fresh modern look ... two geometrical lines that represent the engineering aspect in ... with many things associated with the company. The new ...
(Date:5/22/2015)... Boca Raton, FL (PRWEB) May 22, 2015 ... organization which provides vascular, electrocardiogram (EKG), echocardiogram and ... of David Sempier, a highly respected All American National ... a multi-sport athlete, I find the high level of ... to both the athlete and their athletic trainers, this ...
(Date:5/22/2015)... Steven Winter Associates (SWA) Vice President ... selected by Consulting-Specifying Engineer (CSE) magazine as a young ... in the May/June issue of the publication. , This ... 40 and younger who have, and continue to make ... in other areas of their professional and personal endeavors. ...
(Date:5/22/2015)... Calif. (PRWEB) May 22, 2015 Bryce ... opened Anaheim Fit Body Boot Camp, recently accepted his ... so quickly after the launch of his location evidences ... the Anaheim community. , Fit Body Boot Camp is ... boot camp franchise with hundreds of locations across North ...
Breaking Medicine News(10 mins):Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Healthy Living Brought to Anaheim— New Fitness Boot Camp Acquires 100 Clients 2
... (Feb. 2, 2012) Different kinds of lung cancer ... diseases. According to a University of Colorado Cancer Center ... of the American Cancer Society, different subgroups of non-small ... in the body. The study looked at ...
... By Kathleen Doheny HealthDay Reporter , THURSDAY, Feb. ... tend to eat as much or as little as their dining ... finds that women who share a meal with women they have ... at the same time. "The aim of our study was ...
... of a multicenter study coordinated by researchers at ... investigational urine-based biomarkers are associated with prostate cancers ... life-threatening among men who take a "watchful waiting," ... these markers may lead to the development of ...
... HealthDay Reporter , THURSDAY, Feb. 2 (HealthDay News) -- The ... part in determining your stroke risk, new research suggests. ... for us, in terms of skin cancer for example," noted ... the University of Alabama at Birmingham. "But this examination of ...
... A new study published in the journal Pharmacoepidemiology ... prescription statins directly to consumers are widespread, and that ... public contain very poor levels of information relevant to ... led by Professor David Brown, School of Pharmacy and ...
... High levels of a personality trait called harm avoidance -- ... associated with a higher stroke risk, a new study indicates. ... rated on the 35-item Harm Avoidance Scale. During 3-1/2 years ... percent underwent a brain autopsy. People who scored high ...
Cached Medicine News:Health News:New research confirms need for lung cancer testing 2Health News:If Your Dining Partner Overeats, So May You 2Health News:If Your Dining Partner Overeats, So May You 3Health News:Investigational urine test can predict high-risk prostate cancer in men who chose 'watchful waiting' 2Health News:Lack of Sunlight May Raise Stroke Risk 2
... false signals and contamination caused by ... Barrier Tips offer performance and economy ... (PCR(a)), radioactive isotopes, tissue culture fluids, ... , ,Promega Barrier Tips are made ...
... ART Aerosol Resistant Tips offer a ... ART Tips are designed for applications such ... studies. In addition, ART Tips are excellent ... and forensic studies. ART Tips prevent aerosol ...
Ideal for use with low volume samples on the Biomek robotic pipetting systems, the ART 20R provides guaranteed protection for your expensive workstation....
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
Medicine Products: